SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks to raise HK$1.09 billion (S$181 million) to further grow the ...

Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to support stronger growth in the ...

Amidst global trade tensions, at least five companies from mainland China and Hong Kong are planning IPOs, dual listings, or ...

India anticipates a significant surge in the demand for AI professionals, projecting a need for one million skilled workers ...

SINGAPORE, May 7, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), National ...

India is poised to see a massive surge in demand for Artificial Intelligence (AI) professionals, with projections estimating ...

“Singapore offers a uniquely supportive ecosystem for biotech startups, combining global connectivity, pro-innovation policies, strong IP protection, and ready access to quality suppliers and ...

"Our investment in Nuevocor marks a strategic expansion for Angelini Ventures - into cardiovascular disease, gene therapy, and the Singapore biotech ecosystem. We are excited by Nuevocor's novel ...

At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore in the next 12 to 18 months, four sources said, as Chinese ...